Fastende plasmaglucoseniveauer er signifikant lavere hos patienter, der behandles med EXUBERA end hos dem, der behandles med subkutant insulin. t le
Fasting plasma glucose levels were significantly lower in patients treated with EXUBERA regimens compared with those treated with subcutaneous insulin.